Antibody 97A6
Patent 6323321 Issued on November 27, 2001. Estimated Expiration Date: 
June 30, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 30, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 344271 filed on 06/30/1999US Classes:530/387.2, Anti-idiotypic424/85.1, LYMPHOKINE424/93.1, WHOLE LIVE MICRO-ORGANISM, CELL, OR VIRUS CONTAINING424/94.1, ENZYME OR COENZYME CONTAINING424/130.1, IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL424/152.1, Binds eukaryotic cell or component thereof or substance produced by said eukaryotic cell424/178.1, CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL424/184.1, ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)424/277.1, Cancer cell or component thereof435/4, MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP435/5, Involving virus or bacteriophage435/6, Involving nucleic acid435/7.1, Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay435/7.21, Animal cell435/14, Involving glucose or galactose435/46, In presence of phenyl acetic acid or phenyl acetamide or their derivatives435/70.1, Using tissue cell culture to make a protein or polypeptide435/325, ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE436/95, Glucose436/119, SULFUR CONTAINING436/120, Organic or sulfhydryl containing (e.g., mercaptan, hydrogen, sulfide, etc.)436/169, With reagent in absorbent or bibulous substrate436/170, Plural superposed layers436/500, THYROID HORMONE TESTS (E.G., T3, T4, TBG, TSH, ETC.)436/805, OPTICAL PROPERTY436/806, ELECTRICAL PROPERTY OR MAGNETIC PROPERTY436/808, Automated or kit436/817, Steroids or hormones530/387.1Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbedExaminersPrimary: Chin, Christopher L.Assistant: Cook, Lisa V. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 039/395C12N 005/20 G01N 033/574 G01N 033/577 Foreign Application Priority Data1997-03-05 DEAbstractThe present invention relates to a monoclonal antibody binding an antigen on the megakaryocytic cell line UT-7. The invention further relates to hybridoma cells producing such an antibody.Other References
Field of SearchWHOLE LIVE MICRO-ORGANISM, CELL, OR VIRUS CONTAININGBinds eukaryotic cell or component thereof or substance produced by said eukaryotic cell IMMUNOGLOBULIN, ANTISERUM, ANTIBODY, OR ANTIBODY FRAGMENT, EXCEPT CONJUGATE OR COMPLEX OF THE SAME WITH NONIMMUNOGLOBULIN MATERIAL CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) ENZYME OR COENZYME CONTAINING LYMPHOKINE Cancer cell or component thereof MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP Involving virus or bacteriophage Involving nucleic acid Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay Animal cell Involving glucose or galactose Using tissue cell culture to make a protein or polypeptide In presence of phenyl acetic acid or phenyl acetamide or their derivatives ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE Steroids or hormones SULFUR CONTAINING Organic or sulfhydryl containing (e.g., mercaptan, hydrogen, sulfide, etc.) Automated or kit With reagent in absorbent or bibulous substrate Plural superposed layers OPTICAL PROPERTY Glucose ELECTRICAL PROPERTY OR MAGNETIC PROPERTY THYROID HORMONE TESTS (E.G., T3, T4, TBG, TSH, ETC.) Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed Anti-idiotypic |
| ||||||||||||||
